Revenue | ₹14.74Cr |
Net Profits | ₹5.39Cr |
Net Profit Margins | 36.57% |
Shukra Pharmaceuticals Ltd’s revenue jumped 20.23% since last year same period to ₹14.74Cr in the Q4 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 27.18% jump in its revenue since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit jumped 35.09% since last year same period to ₹5.39Cr in the Q4 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 70.57% jump in its net profits since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit margin jumped 12.36% since last year same period to 36.57% in the Q4 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 34.12% jumped in its net profit margins since last 3-months.
The revenue for Shukra Pharmaceuticals Ltd in the Q4 results 2024 was ₹14.74Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q4 results 2024 was ₹5.39Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q4 results 2024 was 36.57%.
The revenue for Shukra Pharmaceuticals Ltd in the Q4 results 2023 was ₹12.26Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q4 results 2023 was ₹3.99Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q4 results 2023 was 32.54%.